Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length‐dependent axonal degeneration in the absence of demyelination and inflammation (original) (raw)

Journal Article

,

Correspondence to: James Garbern, Department of Neurology and Center for Molecular Medicine and Genetics, 421E. Canfield Room 3206, Wayne State University School of Medicine, Detroit, MI 48201, USA E‐mail: jgarbern@med.wayne.edu

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

,

Search for other works by this author on:

... Show more

Revision received:

01 October 2001

Accepted:

11 October 2001

• • Article contents
  • Figures & tables
  • Video
  • Audio
  • Supplementary Data
• Cite

Cite

James Y. Garbern, Donald A. Yool, Gregory J. Moore, Ian B. Wilds, Michael W. Faulk, Matthias Klugmann, Klaus‐Amin Nave, Erik A. Sistermans, Marjo S. van der Knaap, Thomas D. Bird, Michael E. Shy, John A. Kamholz, Ian R. Griffiths, Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length‐dependent axonal degeneration in the absence of demyelination and inflammation, Brain, Volume 125, Issue 3, March 2002, Pages 551–561, https://doi.org/10.1093/brain/awf043
Close

Navbar Search Filter Mobile Enter search term Search

Abstract

Axonal degeneration contributes to clinical disability in the acquired demyelinating disease multiple sclerosis. Axonal degeneration occurs during acute attacks, associated with inflammation, and during the chronic progressive phase of the disease in which inflammation is not prominent. To explore the importance of interactions between oligodendrocytes and axons in the CNS, we analysed the brains of rodents and humans with a null mutation in the gene encoding the major CNS myelin protein, proteolipid protein (PLP1, previously PLP). Histological analyses of the CNS of Plp1 null mice and of autopsy material from patients with null PLP1 mutations were performed to evaluate axonal and myelin integrity. In vivo proton magnetic resonance spectroscopy (MRS) of PLP1 null patients was conducted to measure levels of _N_‐acetyl aspartate (NAA), a marker of axonal integrity. Length‐dependent axonal degeneration without demyelination was identified in the CNS of Plp1 null mice. Proton MRS of PLP1‐deficient patients showed reduced NAA levels, consistent with axonal loss. Analysis of patients’ brain tissue also demonstrated a length‐dependent pattern of axonal loss without significant demyelination. Therefore, axonal degeneration occurs in humans as well as mice lacking the major myelin protein PLP1. This degeneration is length‐dependent, similar to that found in the PNS of patients with the inherited demyelinating neuropathy, CMT1A, but is not associated with significant demyelination. Disruption of PLP1‐mediated axonal–glial interactions thus probably causes this axonal degeneration. A similar mechanism may be responsible for axonal degeneration and clinical disability that occur in patients with multiple sclerosis.

Topic:

• inflammation
• mutation
• axon
• genes
• mice, knockout
• multiple sclerosis
• myelin proteins
• oligodendroglia
• proteolipids
• protons
• retrograde degeneration
• brain
• mice
• disability
• demyelination
• myelin
• tissue degeneration

You do not currently have access to this article.

Personal account

• Sign in with email/username & password
• Get email alerts
• Save searches
• Purchase content
• Activate your purchase/trial code
• Add your ORCID iD

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

1. Click Sign in through your institution.
2. Select your institution from the list provided, which will take you to your institution's website to sign in.
3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

1. Click Sign in through society site.
2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

• View your signed in personal account and access account management features.
• View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length‐dependent axonal degeneration in the absence of demyelination and inflammation - 24 Hours access

EUR €51.00

GBP £44.00

USD $55.00

Rental

This article is also available for rental through DeepDyve.

Citations

Views

Altmetric

Metrics

Total Views 2,480

1,784 Pageviews

696 PDF Downloads

Since 12/1/2016

Citations

214 Web of Science

×

Email alerts

Citing articles via

• Latest

• Most Read

• Most Cited

More from Oxford Academic